April Calderon
Family Medicine · Austin, TXNPI 1437475191
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 125 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,491 and has fallen 94.5% since, to $82 in 2023.
Across 125 payments — averaging $14.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$300
- AbbVie$288
- AstraZeneca$246
- Lilly USA, LLC$208
- Novo Nordisk$144
- Boehringer Ingelheim$139
- plus $538 from 17 others
What the payments were for
- Food & beverage$1,863100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 21 | $300 |
| AbbVie(2 entities) | 17 | $288 |
| AstraZeneca | 10 | $246 |
| Lilly USA, LLC | 12 | $208 |
| Novo Nordisk | 14 | $144 |
| Boehringer Ingelheim | 9 | $139 |
| Astellas Pharma US Inc | 7 | $107 |
| Amarin Pharma, Inc. | 4 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $57 |
| Johnson & Johnson(2 entities) | 3 | $46 |
| Medtronic | 2 | $35 |
| Stryker | 1 | $33 |
| Circassia Inc. | 2 | $29 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $27 |
| Tactile Systems Technology Inc | 2 | $22 |
| Aytu Biopharma, Inc. | 1 | $19 |
| Amgen | 1 | $17 |
| Abbott | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Merck | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $11 |
| Pfizer | 1 | $11 |
How this compares
$1,863 in reported general payments places this provider in the 70th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $40 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Austin
- Cynthia BrinsonAustin$402K
- David WrightAustin$124K
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.